Last --
Change Today 0.00 / 0.00%
Volume 0.0
4967 On Other Exchanges
Symbol
Exchange
4967 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kazumasa Kobayashi

Chairman and Chief Executive Officer, Kobayashi Pharmaceutical Co. Ltd.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background*

Mr. Kazumasa Kobayashi serves as the Chairman and Chief Executive Officer of Kobayashi Pharmaceutical Co. LTD. Mr. Kobayashi served as the President of KOBAYASHI Pharmaceutical Co Ltd. He served as a Director of MediPal Holdings Corporation.

Corporate Headquarters*

KDX Kobayashi Doshomachi Building
Osaka, -- 541-0045

Japan

Phone: 81 6 6222 0142
Fax: --

Board Members Memberships*

Chairman and Chief Executive Officer
Former Director and Chairman of KOBAYASHI Pharmaceutical Co Ltd

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4967:JP ¥6,410.00 JPY 0.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KOBAYASHI PHARMACEUTICAL CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.